|
Johnny Isakson on Drugs
Republican Jr Senator; previously Rep (GA-6)
|
|
Legalize medical marijuana and cannabis oil
A group of senators introduced a medical marijuana bill that seeks to do what Georgia's did to legalize epilepsy treatments with hemp oil at the federal level. It's different from a recent House version because it allows the FDA more leeway to regulate
the cannabidiol products, thus earning the support of Sen. Johnny Isakson, who said:"This legislation will ensure that families of children suffering from seizures have access to treatments that can provide them with a better quality of life.
The legislation also removes federal barriers for Georgia families who want to bring the cannabis oil back to Georgia in order to administer medical treatment in the comfort of their own home. I've always been a supporter of research and innovation as a
leading driver in finding new and improved treatment options for those affected by diseases and disorders."
Even though Georgia has legalized possession of the drug, it remains illegal to carry it across state lines.
Source: Atlanta Journal Constitution on 2016 Georgia Senate race
, May 14, 2015
Voted YES on military border patrols to battle drugs & terrorism.
Amendment to set up a task force on counter-terrorism and drug interdiction and allow military personnel to help patrol U.S. borders.
Bill HR 2586
; vote number 2001-356
on Sep 25, 2001
Voted YES on prohibiting needle exchange & medical marijuana in DC.
Vote to pass a bill that provides $429.1 million in funds for the District of Columbia and approves the District's $6.8 billion budget. Among other provisions, the bill prohibits the use of federal funds for needle exchange programs, prohibits implementing an approved ballot initiative to legalize the medicinal use of marijuana.
Reference: Bill sponsored by Istook, R-OK;
Bill HR 3064
; vote number 1999-504
on Oct 14, 1999
TV ads to prevent teenage meth use.
Isakson signed S.3278 & H.R.5916
Authorizes matching grants to states, local government, or private nonprofit organizations to establish the Meth Project Prevention Campaign, which shall be aimed at teenagers. Authorizes the use of grant funds for:- television, radio, Internet, and print advertisements and educational materials;
- community outreach to motivate community involvement in methamphetamine education;
- a benchmark survey and periodic studies of attitudes and behaviors related to methamphetamine ; and
- qualitative research to assist in the development and testing of Campaign messaging and the effectiveness of methamphetamine education.
Congress finds that--- methamphetamine is a leading drug threat to the US
- crime related to methamphetamine abuse continues to increase
- methamphetamine laboratories pose a dangerous threat in terms of toxicity, severe environmental and property damage, violence, and public safety
-
24% of teens nationally report it would be easy or somewhat easy to obtain methamphetamine
- 33% of teens believe there is only slight or no risk to trying methamphetamines once or twice
- the annual economic burden of methamphetamine use in the US is estimated at between $16,200,000,000 and $48,300,000,000 annually; and
- there are currently no particular pharmacological treatments for dependence on methamphetamine.
Source: Meth Project Prevention Campaign Grant Program Act 10-HR5916 on Apr 29, 2010
Rated C by NORML, indicating a mixed record on drug reform.
Isakson scores C by the NORML on drug reform
OnTheIssues.org interprets the 2016 NORML scores as follows:
- C-/D/F: "hard-on-drugs" stance (approx. 243 members)
- C: mixed record on drug reform (approx. 45 members)
- A/B: pro-drug-reform stance (approx. 293 members)
About NORML (from their website, www.norml.org): National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.
NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.
NORML supports the removal of all criminal penalties for the private possession
& responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."
NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."
NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.
NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.
Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.
Source: NORML website 16_NORML on Nov 8, 2016
Require chemical resellers to certify against meth use.
Isakson co-sponsored requiring chemical resellers to certify against meth use
Sen. FEINSTEIN: This act is designed to address problems that the Drug Enforcement Administration, DEA, has identified in the implementation of the Combat Methamphetamine Epidemic Act of 2005. The bill that I introduce today would:
- clarify that all retailers, including mail order retailers, who sell products that contain chemicals often used to make methamphetamine--like ephedrine, pseudoepedrine and phenylpropanolamine--must self-certify that they have trained their personnel and will comply with the Combat Meth Act's requirements;
- require distributors to sell these products only to retailers who have certified that they will comply with the law;
- require the DEA to publish the list of all retailers who have filed self-certifications, on the DEA's website;
- and clarify that any retailer who negligently fails to file self-certification as required, may be subject to civil fines and penalties.
The Combat Methamphetamine Epidemic Act that we passed last year has been a resounding success. The number of methamphetamine labs in the United States has declined dramatically now that the ingredients used to make methamphetamine are harder to get. Fewer meth labs means more than just less illegal drug production. In 2003, 3,663 children were reported exposed to toxic meth labs nationwide--but so far this year, the number of exposed children is only 319. This is a common-sense bill, designed to strengthen the implementation of the Combat Methamphetamine Epidemic Act. This bill would create incentives to ensure that the self-certification process of the law is made both effective and enforceable. I urge my colleagues to support this legislation.
Source: Combat Methamphetamine Enhancement Act (S.2071) 2007-S2071 on Sep 19, 2007
|
Other candidates on Drugs: |
Johnny Isakson on other issues: |
GA Gubernatorial: Andrew Hunt Brian Kemp Casey Cagle Hunter Hill Jason Carter Keisha Lance Bottoms Nathan Deal Sonny Perdue Stacey Abrams GA Senatorial: Allen Buckley David Perdue Derrick Grayson Doug Collins Jason Carter Jim Barksdale John Barrow Jon Ossoff Kelly Loeffler Matt Lieberman Ted Terry Teresa Tomlinson Tom Price
GA politicians
GA Archives
|
Senate races 2019-20:
AK:
Sullivan(R,incumbent)
vs.Gross(I)
AL:
Jones(D,incumbent)
vs.Sessions(R)
vs.Moore(R)
vs.Mooney(R)
vs.Rogers(D)
vs.Tuberville(R)
vs.Byrne(R)
vs.Merrill(R)
AR:
Cotton(R,incumbent)
vs.Mahony(D)
vs.Whitfield(I)
vs.Harrington(L)
AZ:
McSally(R,incumbent)
vs.Kelly(D)
CO:
Gardner(R,incumbent)
vs.Hickenlooper(D)
vs.Madden(D)
vs.Baer(D)
vs.Walsh(D)
vs.Johnston(D)
vs.Romanoff(D)
vs.Burnes(D)
vs.Williams(D)
DE:
Coons(D,incumbent)
vs.Scarane(D)
GA-2:
Isakson(R,resigned)
Loeffler(R,appointed)
vs.Lieberman(D)
vs.Collins(R)
vs.Carter(D)
GA-6:
Perdue(R,incumbent)
vs.Tomlinson(D)
vs.Ossoff(D)
vs.Terry(D)
IA:
Ernst(R,incumbent)
vs.Graham(D)
vs.Mauro(D)
vs.Greenfield(D)
ID:
Risch(R,incumbent)
vs.Harris(D)
vs.Jordan(D)
IL:
Durbin(D,incumbent)
vs.Curran(R)
vs.Stava-Murray(D)
KS:
Roberts(R,retiring)
vs.LaTurner(R)
vs.Wagle(R)
vs.Kobach(R)
vs.Bollier(D)
vs.Lindstrom(R)
vs.Grissom(D)
vs.Marshall(R)
KY:
McConnell(R,incumbent)
vs.McGrath(D)
vs.Morgan(R)
vs.Cox(D)
vs.Tobin(D)
vs.Booker(D)
LA:
Cassidy(R,incumbent)
vs.Pierce(D)
|
MA:
Markey(D,incumbent)
vs.Liss-Riordan(D)
vs.Ayyadurai(R)
vs.Kennedy(D)
ME:
Collins(R,incumbent)
vs.Sweet(D)
vs.Gideon(D)
vs.Rice(D)
MI:
Peters(D,incumbent)
vs.James(R)
MN:
Smith(D,incumbent)
vs.Carlson(D)
vs.Lewis(R)
vs.Overby(G)
MS:
Hyde-Smith(R,incumbent)
vs.Espy(D)
vs.Bohren(D)
MT:
Daines(R,incumbent)
vs.Bullock(D)
vs.Collins(D)
vs.Mues(D)
vs.Driscoll(R)
vs.Giese(L)
NC:
Tillis(R,incumbent)
vs.E.Smith(D)
vs.S.Smith(R)
vs.Cunningham(D)
vs.Tucker(R)
vs.Mansfield(D)
NE:
Sasse(R,incumbent)
vs.Janicek(R)
NH:
Shaheen(D,incumbent)
vs.Martin(D)
vs.Bolduc(R)
vs.O'Brien(f)
NJ:
Booker(D,incumbent)
vs.Singh(R)
vs.Meissner(R)
NM:
Udall(D,retiring)
vs.Clarkson(R)
vs.Oliver(D)
vs.Lujan(D)
vs.Rich(R)
OK:
Inhofe(R,incumbent)
vs.Workman(D)
OR:
Merkley(D,incumbent)
vs.Romero(R)
vs.Perkins(R)
RI:
Reed(D,incumbent)
vs.Waters(R)
SC:
Graham(R,incumbent)
vs.Tinubu(D)
vs.Harrison(D)
SD:
Rounds(R,incumbent)
vs.Borglum(R)
vs.Ahlers(D)
TN:
Alexander(R,incumbent)
vs.Sethi(R)
vs.Mackler(D)
vs.Hagerty(R)
TX:
Cornyn(R,incumbent)
vs.Hegar(D)
vs.Hernandez(D)
vs.Bell(D)
vs.Ramirez(D)
vs.West(D)
VA:
Warner(D,incumbent)
vs.Taylor(R)
vs.Gade(R)
WV:
Capito(R,incumbent)
vs.Swearengin(D)
vs.Ojeda(D)
WY:
Enzi(R,incumbent)
vs.Ludwig(D)
vs.Lummis(R)
|
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare
Other Senators
Senate Votes (analysis)
Bill Sponsorships
Affiliations
Policy Reports
Group Ratings
|
Contact info: Fax Number: 202-228-2090 Mailing Address: Senate Office SR-120, Washington, DC 20510 Phone number: (202) 224-3643
|
Page last updated: Jul 14, 2020